SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-044367
Filing Date
2019-11-25
Accepted
2019-11-25 16:01:41
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phat-10q_20190930.htm 10-Q 2281042
2 EX-31.1 phat-ex311_67.htm EX-31.1 16462
3 EX-31.2 phat-ex312_66.htm EX-31.2 16465
4 EX-32.1 phat-ex321_64.htm EX-32.1 7030
5 EX-32.2 phat-ex322_65.htm EX-32.2 6812
  Complete submission text file 0001564590-19-044367.txt   6993496

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT phat-20190930.xml EX-101.INS 1254029
7 XBRL TAXONOMY EXTENSION SCHEMA phat-20190930.xsd EX-101.SCH 56883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phat-20190930_cal.xml EX-101.CAL 33033
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phat-20190930_def.xml EX-101.DEF 222618
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20190930_lab.xml EX-101.LAB 434407
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20190930_pre.xml EX-101.PRE 353420
Mailing Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 650-325-5156
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 191246138
SIC: 2834 Pharmaceutical Preparations